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Abstract
Background: Contents of the epithelial lining fluid (ELF) of the bronchi are of central interest in
lung diseases, acute lung injury and pharmacology. The most commonly used technique
broncheoalveolar lavage is invasive and may cause lung injury. Microdialysis (MD) is a method for
continuous sampling of extracellular molecules in the immediate surroundings of the catheter. Urea
is used as an endogenous marker of dilution in samples collected from the ELF. The aim of this study
was to evaluate bronchial MD as a continuous monitor of the ELF.
Methods: Microdialysis catheters were introduced into the right main stem bronchus and into the
right subclavian artery of five anesthetized and normoventilated pigs. The flowrate was 2 µl/min and
the sampling interval was 60 minutes. Lactate and fluorescein-isothiocyanate-dextran 4 kDa (FD-4)
infusions were performed to obtain two levels of steady-state concentrations in blood. Accuracy
was defined as [bronchial-MD] divided by [arterial-MD] in percent. Data presented as mean ± 95
percent confidence interval.
Results:  The accuracy of bronchial MD was calculated with and without correction by the
arteriobronchial urea gradient. The arteriobronchial lactate gradient was 1.2 ± 0.1 and FD-4
gradient was 4.0 ± 1.2. Accuracy of bronchial MD with a continuous lactate infusion was mean
25.5% (range 5.7–59.6%) with a coefficient of variation (CV) of 62.6%. With correction by the
arteriobronchial urea gradient accuracy was mean 79.0% (57.3–108.1%) with a CV of 17.0%.
Conclusion: Urea as a marker of catheter functioning enhances bronchial MD and makes it useful
for monitoring substantial changes in the composition of the ELF.
Background
The epithelial lining fluid of the lung is important in the
understanding mechanisms in acute lung injury, inflam-
matory lung diseases, cardiac failure, and in pharmacoki-
netic studies.
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Today there are no established methods of direct continu-
ous monitoring of the epithelial lining fluid of the lower
respiratory tract. The epithelial lining fluid of the bronchi
has been examined by bronchioalveolar lavage (BAL),
direct aspiration, microsampling, and exhaled breath con-
densates. BAL and other bronchoscopic techniques have
in common that they are invasive, may create lung injury,
are based on single or intermittent samples and therefore
have limited value as continuous and dynamic monitors
of the epithelial lining fluid of the lung. The exhaled
breath condensates technique is non-invasive and contin-
uous, but is indirect and best suited for collection of non-
volatile hydrophilic solutes[1].
Microdialysis is a method for continuous sampling of
extracellular molecules in the immediate surroundings of
the catheter. The technique is based on the principle of
diffusion of substances along a concentration gradient
through a semipermeable membrane on a thin catheter
with an outer diameter of 0.6 mm. Microdialysis has rou-
tinely been used in parenchymatous organs and tissues,
but has also gained widespread acceptance in hollow
organs. Intestinal endoluminal microdialysis has been
used as a continuous monitor of intestinal dysfunction
both in experimental [2-4] and in clinical settings[5]. As
far as we know there is only one published article on
bronchial microdialysis in rats for pharmacokinetic meas-
urements of aminoglycosides[6]. The value of microdialy-
sis as a continuous and dynamic monitor of the time to
time changes in the epithelial lining fluid has not previ-
ously been evaluated.
The recovered amount of epithelial lining fluid by various
techniques, especially BAL, has been estimated by endog-
enous and exogenous markers of dilution. Urea (60 Da) is
a small molecule in equilibrium in all body compart-
ments. The recovered concentration of urea has been used
as an indicator of the recovered concentration of epithe-
lial lining fluid in the dialysate [7-10]. The arteriobron-
chial urea gradient has been used to calculate the absolute
concentration of the molecules measured in the epithelial
lining fluid by BAL and the ureagradient has also been
used to calculate the absolute concentration of molecules
measured in the extracellular fluid[9,11].
Lactate (90 Da) is a small molecule which has previously
been studied as a marker of intestinal barrier dysfunc-
tion[2]. In the intestines lactate only passes the blood-
luminal barrier of the intestines when the intestines suffer
an ischemia-reperfusion injury[4]. The question is if lac-
tate freely passes the blood-bronchial barrier.
Molecular transport across rat epithelial monolayer by the
paracellular route has previously been investigated with
the macromolecule fluorescein isothiocyanate dextran
4000 Da (FD-4)[12,13]. According to the present litera-
ture an increased leakage of FD-4 is believed to be via the
paracellular route by changes in the composition and con-
firmation of the tight junctions of the epithelium and the
endothelium in response to stimuli[14,15]. In this study,
we used FD-4 to see if larger molecular size influences the
gradient across the paracellular blood-bronchial barrier.
The aim of our study was to evaluate bronchial microdial-
ysis as a possible method for continuous and dynamic
monitoring of the time to time changes in the composi-
tion of the epithelial lining fluid. Lactate and FD-4 were
measured during two levels of steady-state concentrations
in anesthetized pigs under positive pressure ventilation.
Arteriobronchial urea gradient was used as a correction
factor to calculate the absolute concentration of lactate
and FD-4 in the bronchial epithelial lining fluid.
Methods
Anesthesia and surgical preparation
Five outbred pigs (Norwegian Landrace 50%, Duroc 25%,
Yorkshire 25%) (range 22–31 kg) were acclimatized and
treated in accordance with the "European Convention for
the Protection of Vertebrate Animals used for Experimen-
tal and Other Scientific Purposes", Strasbourg,
18.III.1986. The pigs fasted overnight with free access to
water prior to the experiment. They were premedicated
with intramuscular diazepam 10 mg (Stesolid, Dumex-
Alpharma, Copenhagen, Denmark) and azaperon 400 mg
(Stresnil, Janssen-Cilag, Vienna, Austria), and anesthesia
was induced with atropine 1 mg (Nycomed Pharma AS,
Oslo, Norway), ketamin HCl 10 mg/kg (Parke-Davis,
Solna, Sweden) and thiopenthal sodium 10 mg/kg (Pen-
tothal, Abbot Scandiavia AB, Solna, Sweden).
Tracheostomy was performed with the pig in the supine
position, and an endotracheal tube 8.0 was inserted 5 cm.
The pigs received total intravenous anesthesia with a con-
tinuous infusion of fentanyl 20 to 30 µg/kg/hour (Fenta-
nyl, Pharmalink, Spanga, Sweden) and ketamin HCl 8 to
12 mg/kg/hour. Pancuronbromide 2 mg/ml (Pavulon,
Organon Teknika, Baxtel, The Netherlands) was used as
needed to eliminate spontaneous ventilation.
The pigs were ventilated in pressure control mode with a
positive end expiratory pressure of 7 cmH2O, a peak
inspiratory pressure less than or equal to 20 cmH2O and
a tidal volume of 6 to 8 ml/kg (Servo Ventilator 900C, Sie-
mens-Elema, Sweden)[16,17].
After a recruitment maneuver of 3 breaths at 40 cmH2O,
respiratory rate was adjusted to an arterial partial pressure
of carbon dioxide (PaCO2) of 4.5 to 5.5 kPa in baseline.
Fraction of inspired oxygen (FiO2) was maintained at 25%Respiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
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during the experiment. Similar recruitment maneuvers
were performed when the bronchial microdialysis cathe-
ter was in position. In 2 out of 5 pigs a recruitment
maneuver was necessary during the experimental protocol
due to spontaneous ventilation in conflict with the venti-
lator and derecruitment. This was solved with pancuro-
nium bromide, increased infusion of the anesthetetic
agents and a recruitment maneuver to reestablish the lung
compliance as measured by lung tidal volume/peak
inspiratory measure.
The pigs received an intravenous infusion of heated
(37°C) Ringers acetate at 14 to 18 ml/kg/hour throughout
the experiment. Rectal temperature was maintained
within the normal range (37 to 39.6°C) by a heating mat-
tress[18].
The right femoral artery was cannulated with a triple
lumen catheter (Certofix-Trio S715, Braun, Melsungen,
Germany) for sampling of arterial blood gases and inva-
sive blood pressure monitoring (Tram-rac 4A/Tram-scope
12C, Marquette Electronics, USA). A single lumen catheter
(Sekalon-T 16G, Becton Dickinson, Singapore) was
inserted in the femoral vein for blood sampling. The right
carotid artery and the right jugular vein were surgically
prepared. A pulmonary artery catheter (Swan Ganz
CCOmbo 7.5 Fr, Edwards Lifescience, USA) was inserted,
and positioned using the pulmonary arterial blood pres-
sure curve and the pulmonary artery wedge pressure curve.
Continuous cardiac output and central venous saturation
were monitored (Vigilance, Edwards Lifescience, USA).
Microdialysis
Alongside the 8.0 endotracheal tube a 4.0 endotracheal
tube was inserted into the trachea and advanced to a posi-
tion 1 cm proximal to the carina confirmed by fiberoptic
bronchoscopy. A thread was used to secure the two tra-
cheal tubes and to avoid air leakage. The microdialysis
catheter (CMA Custom made, 10 mm membrane length,
100 kDa cut-off, outer diameter 0.6 mm, CMA Microdial-
ysis, Stockholm, Sweden) was introduced through the 4.0
endotracheal tube and guided fiberoptically into the left
main stem bronchus. The microdialysis catheter was gen-
tly guided forward until wedged and then retracted 0.5 to
1 cm to avoid atelectasis. The proximal opening of the 4.0
endotracheal tube was sealed with wax to avoid air leak-
age.
Another microdialysis catheter (CMA Custom made, 10
mm membrane length, 100 kDa cut-off, outer diameter
0.6 mm, CMA Microdialysis, Stockholm, Sweden) was
inserted into the right subclavian artery through a venous
catheter (Optiva2 18G, Medex, Great Britain) in the right
brachial artery.
Both microdialysis catheters were connected to microdial-
ysis pumps (CMA 107, CMA Microdialysis AB, Stock-
holm, Sweden) and perfused by sterile phosphate
buffered saline (PBS) at a flow rate of 2 µl/min.
The microdialysis catheters were perfused with a flow of 2
µl/min. The volume on the inside of the membranous
part of the microdialysis catheters used in this study was
less than 1.4 µl. Thus the time period of membrane con-
tact of the microdialysis perfusion fluid was short.
The catheters were perfused in situ for ≥60 minutes before
the experiment was started. Samples from each microdial-
ysis catheter were collected in microvials that were
exchanged every 60 minutes, and analyzed online for lac-
tate and urea on the CMA 600 (CMA Microdialysis AB,
Stockholm, Sweden), using the peroxidase methodology.
To verify the position of the catheter at the end of the
experiment, the microdialysis catheter either was perfused
with methylene blue and the bronchial tree dissected or
the catheter was left in situ and the bronchial tree dis-
sected (figure 1).
Experimental protocol
After surgical preparations the animals were allowed to
stabilize for 60 minutes.
Lactate
An infusion of sodium lactate ~50% (Merck KGaA, Darm-
stadt, Germany) was adjusted to an arterial blood lactate
The microdialysis catheter in situ Figure 1
The microdialysis catheter in situ. The picture shows 
the microdialysis catheter in the distal bronchus. The distal 
white part is the microdialysis membrane. It is this part of the 
catheter that is in contact with the epithelial lining fluid and 
collects molecules by diffusion.Respiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
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concentration of ~5 mmol/l for 120 minutes. Thereafter,
the infusion rate was increased to an arterial blood lactate
concentration of ~10 mmol/l (figure 2). Arterial blood
was collected every 15 minutes throughout the experi-
ment to establish a steady-state of lactate and PaCO2
(ABL700, Radiometer Copenhagen, Denmark).
Fluorescein isothiocyanate dextran 4000 Da infusion
A solution of FD-4 (Sigma Chemical, St. Louis, MO, USA)
in PBS was prepared fresh each day at a concentration of
10 mg/ml. The FD-4 infusion started with an intravenous
loading dose of 10 mg/kg over 10 min followed by an
infusion of 5 mg/kg/hour for 180 minutes. Then parallel
to the FD-4 infusion at 5 mg/kg/hour a new bolus of 10
mg/kg was given. After the bolus the infusion was
increased to 10 mg/kg/hour for the last 180 minutes of the
experiment (figure 3).
Beginning during in the stabilizing period, 0.5 ml of arte-
rial blood was sampled every 60 minutes throughout the
experiment. Fluorescence of plasma and microdialysate
samples was measured on a fluorescence spectrophotom-
eter (Fluoroskan II, Labsystem).
Arteriobronchial urea gradient
Urea concentrations are the same throughout various
body compartments. The arteriobronchial urea gradient
in each sampling period is a measure of the microdialysis
catheter functioning in the bronchial as opposed to the
arterial compartment.
In vivo recovery
Blood lactate was measured every 30 minutes. Mean arte-
rial blood concentration of lactate during a 60-minutes
period was defined as the mean of the value at 0, 30 and
60 minutes for the period.
Arterial blood FD-4 was measured every 60 minutes.
Mean arterial blood concentration of FD-4 during a 60-
minutes period was defined as the mean of the value at 0
and 60 minutes for the period
Overview of the fluorescein isothiocyanate dextran 4000 Da  (FD-4) infusion with two steady states Figure 3
Overview of the fluorescein isothiocyanate dextran 
4000 Da (FD-4) infusion with two steady states. Data 
are presented as mean FD-4 values by arterial microdialysis 
(solid line) with mean values in steady state (filled triangles), 
bronchial microdialysis (long dash line) with mean values in 
steady state (filled circles) and ureacorrected bronchial 
microdialysis (dash-dot line) with mean values in steady state 
(open circles). The circles and the triangles represent the 
time where the microdialysis vials were exchanged for the 
steady state samples. The gray area is a graphical presenta-
tion of the intravenous FD-4 infusion. The infusion was 
started with an intravenous bolus of 10 µg/kg over 10 min-
utes. In the low steady state an infusion of FD-4 at 5 µg/kg/
hour was maintained. After the low steady state a new intra-
venous FD-4 bolus of 10 µg/kg over 10 minutes was infused. 
In the high steady state an infusion of FD-4 at 10 µg/kg/hour 
was maintained.
Overview of the lactate infusion with two steady states Figure 2
Overview of the lactate infusion with two steady 
states. Data are presented as mean lactate values by arterial 
microdialysis (solid line) with mean values in steady state 
(filled triangles), bronchial microdialysis (long dash line) with 
mean values in steady state (filled circles) and ureacorrected 
bronchial microdialysis (dash-dot line) with mean values in 
steady state (open circles). The circles and the triangles rep-
resent the time where the microdialysis vials were 
exchanged for the steady state samples. The gray area is a 
graphical presentation of the intravenous lactate infusion. 
During the low steady state the infusion of sodium lactate 
was gradually increased to maintain an arterial blood lactate 
of ~5 mmol/L. During the high steady state the infusion of 
sodium lactate was increased to maintain an arterial blood 
lactate of ~10 mmol/L.Respiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
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Arterial microdialysis was sampled over the same 60-
minute period.
In vivo recovery was calculated as [Molecule]arterial microdial-
ysis/[Molecule]arterial blood.
In vitro microdialysis
Lactate wells were prepared in PBS at lactate concentra-
tions of ~1, ~5 and ~10 mmol/L. Three microdialysis cath-
eters (CMA20, 10 mm membrane length, 100 kDa cut-off,
outer diameter 6 mm, CMA microdialysis, Stockholm,
Sweden) were perfused with PBS at 2 µl/min and put in
the first well, lactate ~1 mmol/L, for 60 minutes to stabi-
lize. Thereafter vials were exchanged every 60 minutes for
180 minutes. Samples from the wells were collected and
analyzed at the beginning and at the end of the experi-
ment. The procedure was then repeated for lactate ~5 and
~10 mmol/L. All lactate samples were analyzed on the
CMA 600 (CMA Microdialysis AB, Stockholm, Sweden).
The procedure was repeated for FD-4 wells prepared with
PBS at FD-4 concentrations of ~10, ~50 and ~150 µg/ml.
This setup gave good and stable volume recovery with FD-
4 samples being analyzed in triplicate or quadruplicate,
each well containing 25 µl (Fluoroskan II, Labsystem).
In vitro recovery was calculated as [Molecule]well microdialy-
sis/[Molecule]well.
Statistics and calculations
Arterial microdialysis values were considered to be the
real arterial concentration during each sample period.
Bronchial values are presented with and without correc-
tion by the arteriobronchial urea gradient. Ureacorrection
was done in accordance to the formula in Rennard's arti-
cle[9]. ([Urea]arterial/[Urea]bronchial)/([Molecule]arterial/
[Molecule]bronchial).
Evaluation of bronchial microdialysis and urea-corrected
bronchial microdialysis as an approximation of arterial
microdialysis are presented as accuracy. The bronchial
microdialysis values, corrected and uncorrected, are pre-
sented as fractions of the arterial microdialysis values.
Accuracy = [Molecule]bronchial/[Molecule]arterial. To evalu-
ate the benefit of the urea correction, the coefficient of var-
iation was used. Coefficient of variation = Standard
deviation/Mean·100.
Calibrations of the microdialysis catheters were done by
in vitro experiments and in vivo calculations. In vitro rel-
ative recovery = [Molecule]well microdialysis/[Molecule]well. In
vivo relative recovery = [Molecule]arterial microdialysis/[Mole-
cule]arterial blood.
The data are presented as values and mean ± 95% confi-
dence interval. Paired t-test was used to compare means
between arterial, bronchial and urea-corrected bronchial
microdialysis with significance defined as p < 0.05.
Results
Circulatory and respiratory measurements
Heart rate, mean artery pressure, cardiac output, central
venous oxygen saturation and partial pressure of carbon-
dioxide remained stable throughout the entire experiment
(table 1).
Recovery measurements
The in vivo lactate relative recovery was 105.9 ± 7.2%. The
in vivo FD-4 relative recovery was 28.8 ± 4.4%.
The in vitro lactate relative recovery was 54.9 ± 3.2%. The
in vitro FD-4 relative recovery was 14.2 ± 1.0%.
Arteriobronchial urea gradient
Arterial urea by microdialysis was 3.69 ± 0.59 mmol/L.
Bronchial urea by microdialysis was 1.19 ± 0.21 mmol/L.
Arteriobronchial urea gradient was 3.78 ± 0.85.
Lactate
During the steady-state periods lactate measured by arte-
rial microdialysis was 6.5 ± 0.9 and 11.8 ± 1.4 mmol/L, by
bronchial microdialysis 1.5 ± 0.8 and 3.0 ± 0.9 mmol/L
and by urea-corrected bronchial microdialysis 5.5 ± 0.8
and 9.6 ± 1.3 mmol/L respectively. There was an arterio-
bronchial gradient of 1.2 ± 0.1 for lactate as measured by
arterial microdialysis and bronchial microdialysis, cor-
rected by the arteriobronchial urea gradient. Steady-state
values and mean values for arterial lactate, bronchial lac-
Table 1: Central hemodynamic and respiratory variables.
Parameter Stabilizing Low steady state High steady state
Mean arterial pressure (mmHg) 65 ± 3 64 ± 2 60 ± 1
Heart rate (beats/min) 81 ± 15 88 ± 6 89 ± 3
Cardiac output (l/min) 4.2 ± 0,9 4.8 ± 0.4 4.9 ± 0.4
Central venous oxygen saturation (percent) 59 ± 5 62 ± 3 60 ± 3
Arterial partial pressure of carbon dioxide (kPa) 4.81 ± 0.23 4.78 ± 0.09 4.94 ± 0.11
Values are mean ± 95% confidence interval.Respiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
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tate and urea-corrected bronchial lactate, as measured by
microdialysis are presented in figure 4. Paired t-test show
a significant difference (p < 0.05) between lactate by arte-
rial microdialysis and urea-corrected bronchial microdial-
ysis at low steady state (blood lactate ~5 mmol/L).
The accuracy of bronchial microdialysis with a continuous
lactate infusion was mean 0.26 ± 0.08 with a coefficient of
variation of 62.6%. The accuracy of bronchial microdialy-
sis with a continuous lactate infusion and a correction by
the arteriobronchial urea gradient was mean 0.81 ± 0.06
with a coefficient of variation of 17.0% (figure 5). The
reduction in the coefficient of variation is in accordance
with urea being a molecule in almost immediate equilib-
rium within all body compartments and thereby is a cor-
rection factor of bronchial microdialysis catheter
functioning.
Non-microdialysis data are presented in table 2.
Fluorescein isothiocyanate dextran 4000 Da
During the steady-state periods FD-4 measured by arterial
microdialysis was 6.5 ± 1.9 and 16.0 ± 4.0 µg/ml, by bron-
chial microdialysis 0.7 ± 0.3 and 1.2 ± 0.5 µg/ml and by
urea-corrected bronchial microdialysis 2.2 ± 0.6 and 5.3 ±
2.5 µg/ml respectively. There was an arteriobronchial gra-
dient of 4.0 ± 1.2 for FD-4 as measured by arterial micro-
dialysis and bronchial microdialysis, corrected by the
arteriobronchial urea gradient. Steady-state values and
means for arterial FD-4, bronchial FD-4 and ureacorrected
bronchial FD-4, as measured by microdialysis, are pre-
sented in figure 6. There was a defined barrier between
blood and bronchi for the diffusion of FD-4.
The accuracy of bronchial microdialysis with a continuous
FD-4 infusion was mean 0.09 ± 0.03 with a coefficient of
variation of 65.2%. The accuracy of bronchial microdialy-
sis with a continuous FD-4 infusion and a correction by
the arteriobronchial urea gradient was mean 0.35 ± 0.10
with a coefficient of variation of 54.8%. The reduction in
the coefficient of variation was less than expected. Previ-
ous knowledge of FD-4 analyses on the Fluoroskan II is
Accuracy of bronchial microdialysis of lactate Figure 5
Accuracy of bronchial microdialysis of lactate. All val-
ues (gray circles) and mean (-) are presented. One value 
(open circle) is excluded as an outlier due to extreme devia-
tion in the arterial microdialysis value. The accuracy of bron-
chial microdialysis with a continuous lactate infusion was 
mean 0.26 ± 0.08 with a coefficient of variation of 62.6%. The 
accuracy of bronchial microdialysis with a continuous lactate 
infusion and a correction by the arteriobronchial urea gradi-
ent was mean 0.81 ± 0.06 with a coefficient of variation of 
17.0%. The reduced coefficient of variation after correction 
by the arteriobronchial ureagradient sustains the ureacorrec-
tion as useful correction factor to estimate the absolute con-
centrations of molecules in the epithelial lining fluid as 
measured by microdialysis.
Microdialysate lactate Figure 4
Microdialysate lactate. All values (gray circles) and mean 
(-) are presented. Lactate values by corrected bronchial 
microdialysis are corrected by the arteriobronchial urea gra-
dient. * Paired T-test showed significant difference from arte-
rial microdialysis at low steady state (arterial blood lactate 
~5 mmol/L) (p < 0.05). † Paired t-test showed significant dif-
ference from arterial microdialysis at high steady state (arte-
rial blood lactate ~10 mmol/L) (p < 0.05). ns Non significant 
from arterial microdialysis at high steady state (arterial blood 
lactate ~10 mmol/L).Respiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
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from experiments with wells containing 150 µl. Due to
small volumes sampled by microdialysis, pilot in vitro
studies were conducted with wells containing 15 µl, 25 µl
and 40 µl. With wells containing 15 µl there was a great
variance and by visual inspection we saw that this small
volume did not cover the bottom of the well. Wells con-
taining 25 µl and 40 µl gave similar results and variance
(data not shown). During analysis of the last fluorescein
isothiocyanate results from the in vivo experiment, we
registered that wells with higher concentrations of FD-4
increased the registered result of neighboring wells with
lower concentration of FD-4. Due to lack of material the
analysis could not be repeated and controlled.
Non-microdialysis data are presented in table 2.
Individual correlation
To evaluate bronchial microdialysis as a tool of continu-
ous monitoring all pigs are presented in XY-plots with
individual values and correlation lines (figure 7). There
was a significant improvement in the correlation between
urea-corrected bronchial and arterial lactate values versus
bronchial and arterial lactate values by paired t-test. For
fluorescein isothiocyanate, the improvement was only a
tendency and did not reach significance.
Discussion
Extensive research on the bronchial epithelial lining fluid
has been done to understand mechanisms of permeabil-
ity, pharmacokinetics and pathophysiology. The lack of
techniques for continuous monitoring and the possibility
of causing lung injury have limited previous work to
describe the dynamics of physiological phenomena. Lung
microdialysis as previously described, with an open surgi-
cal technique and "interstitial" introduction of the micro-
dialysis catheter by visual control, is only suitable for
patients undergoing thoracic surgery [19-21].
This study indicates that bronchial microdialysis can be
used as a continuous monitor of the epithelial lining
fluid. Correction of bronchial microdialysis by the arteri-
obronchial urea gradient enhances bronchial microdialy-
sis, as measured by lactate, by reducing the coefficient of
variation. Correction by the arteriobronchial urea gradi-
ent makes bronchial microdialysis suitable as a monitor
of substantial concentration changes in the epithelial lin-
ing fluid.
There is an ongoing controversy on how to estimate the
amount of epithelial lining fluid recovered. Urea rapidly
diffuses and equilibrates into the total volume sampled
with BAL technique. Therefore recovered concentration of
urea as a marker of recovered concentration of epithelial
lining fluid has a tendency to overestimate the recovered
concentration of epithelial lining fluid and hence under-
estimate the bronchial concentration of the measured
molecule. Total BAL volumes in humans vary from 100 to
300 ml[9,22]. The tendency of overestimating the recov-
ered volume of epithelial lining fluid also increases with
increasing dwell time with BAL technique. The dwell time
of BAL varies from about 3 to more than 10 minutes.
Technetium-99 m diethylenetriaminepenta-acetic acid
has been used as an alternative marker of recovered con-
centration of epithelial lining fluid without the problem
Microdialysate fluorescein isothiocyanate dextran 4000 Da Figure 6
Microdialysate fluorescein isothiocyanate dextran 
4000 Da. All values (gray circles) and mean (-) are pre-
sented. Fluorescein isothiocyanate dextran 4000 Da (FD-4) 
values by corrected bronchial microdialysis are corrected by 
the arteriobronchial urea gradient. * Paired t-test showed 
significant difference from arterial microdialysis at low steady 
state (FD-4 5 µg/kg/hour) (p < 0.05). † Paired t-test showed 
significant difference from arterial microdialysis at high steady 
state (FD-4 10 µg/kg/hour) (p < 0.05).
Table 2: Non-microdialysis data.
Parameter Low steady state High steady state
Lactate (mmol/L) 5.9 ± 0.4 11.2 ± 0.3
Fluorescein isothiocyanate 
dextran 4000 Da (µg/ml)
25.2 ± 3.8 49.5 ± 6.7
Lactate was measured in blood and fluorescein isothiocyanate 
dextran 4000 Da was measured in plasma. Non-microdialysis data 
are intermittent samples and not continuous measurements. Values 
are mean ± 95% confidence interval.Respiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
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of additional influx in the instilled lavage volume[23].
However the method is time consuming and this limits its
applicability in both clinical and experimental settings.
With small volume lavage (3 aliquots of 1 ml) with short
dwell time (less than 1 minute) urea is a valid marker of
dilution in BAL fluids in both the normal, diseased and
recovering lung in infants, according to Dargaville et al[7].
With microdialysis, the additional volume to equilibrate
was minimal (less than 1.4 µl), limited to the volume on
the inside of the semi-permeable membrane of the cathe-
ter. With a perfusion flow of 2 µl/minute and the short
time period of contact between the microdialysis per-
fusion fluid and the epithelial lining fluid, the arterio-
bronchial urea gradient was a reasonable correction factor
XY-plot of bronchial and corrected bronchial microdialysis data against arterial microdialysis data of lactate and fluorescein iso- thiocyanate dextran 4000 Da Figure 7
XY-plot of bronchial and corrected bronchial microdialysis data against arterial microdialysis data of lactate 
and fluorescein isothiocyanate dextran 4000 Da. All five pigs are represented; number one closed circles and line, 
number two open circles and dotted line, number three closed triangles and medium dashed line, number four open triangles 
and dash-dot-dot line, and number five closed squares and long dashed line. Plot A and B show arterial lactate along the X-axis 
and bronchial (R2 0.82 ± 0.18) and ureacorrected bronchial lactate (R2 0.91 ± 0.11) along the Y-axis respectively. Paired t-test 
of R2 for the individual bronchial and ureacorrected bronchial lactate XY-plots showed significant difference (p < 0.05). Plot C 
and D show arterial fluorescein isothiocyanate dextran 4000 Da (FD-4) along the X-axis and bronchial (R2 0.53 ± 0.38) and 
ureacorrected bronchial FD-4 (R2 0.72 ± 0.34) along the Y-axis. Paired t-test of R2 for the individual bronchial and ureacor-
rected bronchial FD-4 XY-plots was not significant.Respiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
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for the recovered concentration of epithelial lining fluid.
Thus it could be a correction factor to calculate the abso-
lute concentrations of lactate and FD-4 in the epithelial
lining fluid[7,10,11,23].
In vivo studies of transport of molecules are complicated
by the metabolic activity of the organism. Molecules will
to some extent be depositioned both extra- and intracell-
uarly. Metabolism in all tissues and renal clearance of the
molecule one measures are factors that must be corrected
and/or considered when the conclusions are drawn.
Lactate is depositioned in all body compartments, espe-
cially red blood cells and muscle[24]. The lung itself is a
possible producer of lactic acid[25]. Urea (60 Da) and lac-
tate (90 Da) differ in size and shape and may have differ-
ent diffusion properties over the blood-bronchial barrier.
Lactate passed the blood-bronchial barrier rather freely
with a gradient of 1.2:1. Whether the gradient is a true
blood-bronchial gradient is not known at present.
FD-4 crossed the blood-bronchial barrier with a gradient
of about 4:1. As described previously in monolayer cell
cultures of rat alveolar epithelial cells, FD-4 is transported
through paracellular pores in human cultured alveolar
epithelial cell monolayer[26]. FD-4 was chosen as a mac-
romolecule with restricted transport through paracellular
pores. Matsukawa showed this in rat alveolar epithelial
cell monolayer[12]. As far as we know there is no previous
study that describes FD-4 transport in vivo across the
blood-bronchial barrier. In our study FD-4 had to cross
intact endothelium, lung interstitium and lung epithe-
lium. Due to methodological limitations with small vol-
ume samples, our FD-4 results varied. The blood-
bronchial gradient was 4.0:1 ± 1.2. FD-4 was transported
across the blood-bronchial barrier with restriction, in
accordance with previous findings, but this requires fur-
ther research to be confirmed.
The arteriobronchial urea gradient as a marker of bron-
chial catheter function reduced the coefficient of variation
from 62.6% to 17.0% of the bronchial microdialysis as
measured for lactate. The arteriobronchial urea gradient
significantly improved correlation of arterial and bron-
chial lactate sampled over the same time interval in the
same pig. A coefficient of variation of 17% still limits the
use of bronchial microdialysis in the measurement of
minor changes in lactate concentration of the bronchial
epithelial fluid.
Bronchial microdialysis has some limitations. Bronchi are
relatively stiff lumens with continuous movements during
the respiratory cycle. The epithelial lining fluid is only a
thin film. Microdialysis is developed for analyzing the
composition of extracellular fluids in compact tissues
with little movement. In the bronchi, one must assume
that only varying parts of the microdialysis membrane are
in contact with the epithelial lining fluid during the respi-
ratory cycle. Thus, a marker of catheter functioning is nec-
essary for characterizing each individual microdialysis
catheter, measuring the recovered amount of epithelial
lining fluid and the absolute concentrations of the mole-
cules in the epithelial lining fluid.
With correction of bronchial microdialysis by the arterio-
bronchial urea gradient, the coefficient of variation of FD-
4 decreased only slightly, from 65.2% to 54.8%. There
was only a tendency toward improved correlation
between arterial and bronchial FD-4 sampled over the
same time interval in the same pig. The pilot studies on
concentration and variation of different volumes on fluo-
rescence spectrophotometry concluded that 25 µl in each
well was sufficient to get precise numbers with a small
degree of variation. But the FD-4 results from our study
were not optimal with a high degree of variation. One of
the problems was that wells with high concentration of
FD-4 increased the measured FD-4 concentration in
neighboring wells with low concentration of FD-4 accord-
ing to our fluorescence spectrophotometer. This problem
could be a contributing factor to the lack of precision with
our method. The lack of reduction in the coefficient of var-
iation of FD-4 by urea correction is probably due to meth-
odological errors in analyzing FD-4 in small volumes by
fluorescence spectrophotometry. Thus FD-4 measurement
in small volumes still has to be refined to increase the pre-
cision of the method.
In vivo lactate recovery was more than 100% (105.9 ±
7.2%). The non-microdialysis samples were analyzed in
whole blood. The microdialysis probe was placed in
plasma in the subclavian artery. The plasma lactate is
higher than the lactate value in erythrocytes[27].
In our laboratory we have shown that the CMA 600 (CMA
Microdialysis AB, Stockholm, Sweden) and the ABL700
(Radiometer Copenhagen, Denmark) return different
results from the same sample with a known lactate con-
centration (data not shown). The CMA600:ABL700 ratio
for lactate in our laboratory is mean 1.13:1. The in vivo
recovery percent for lactate must be evaluated with these
factors in mind.
There was a major difference, about 2:1, between in vivo
and in vitro recovery. In vitro the microdialysis catheter
was placed in a well, collecting molecules from the imme-
diate surroundings. In general, this means that there will
always be a concentration gradient within the well around
the membrane of the microdialysis catheter. Accordingly,
there was a local concentration gradient and a smaller
concentration of the measured molecule in the immediateRespiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
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surroundings of the microdialysis catheter. This effect
increased with increasing perfusion volume per time unit.
2 µl/min is a relatively high perfusion rate with the micro-
dialysis technique. In vivo, the catheter was in the arterial
bloodflow with a continuous replacement of the fluid sur-
rounding the microdialysis membrane so that the concen-
tration of the measured molecule was the same in the
immediate surroundings of the microdialysis membrane
as in the rest of the fluid compartment.
Based on good volume recovery in the in vitro experi-
ments, an isotonic crystalloid perfusion fluid was chosen.
A microdialysis membrane with 100 kDa cut-off has large
pores which easily can contribute to a loss of collected vol-
ume limiting the possibility for analyzing triplicates. The
literature indicates that use of a colloid perfusion fluid
increases the recovered volume, but has no significant
influence on the concentration of the sampled molecules
at a perfusion rate of 2 µl/min[28]. Thus a colloid per-
fusion fluid would probably increase the recovered vol-
ume and more frequently allow triplicate analyses of each
sample and larger volumes in each analysis.
The method as presented in this study is well suited for
monitoring substantial changes in the composition of the
epithelial lining fluid as seen with major physiological
trauma such as sepsis and ischemia-reperfusion injury,
and may even be used in the clinical setting. Combining
the application of microdialysis in the bronchi with
present knowledge of the microdialysis technique can
provide better knowledge of the dynamics of the epithe-
lial lining fluid in normal (pharmacokinetics) and patho-
logical processes (altered permeability and measurement
of markers of inflammation).
Conclusion
Bronchial microdialysis is an applicable continuous mon-
itor of the dynamic changes in the composition of the epi-
thelial lining fluid. The absolute concentrations of the
measured molecules can be estimated with acceptable
precision using a correction by the arteriobronchial urea
gradient.
Further research on bronchial microdialysis has to be
done.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
SST, ES and PA have made major contributions to concep-
tion and design of the study. OL, SLS and SG have made
major contributions to conception and design on labora-
tory methods and surgical preparations. All have contrib-
uted in the acquisition of data. SST, OL and ES have made
major contributions in analysis and interpretation of the
data. All have been involved in drafting the manuscript or
revising it critically for important intellectual content. All
have given final approval of the version to be published.
References
1. Effros RM, Dunning MB III, Biller J, Shaker R: The promise and per-
ils of exhaled breath condensates.  Am J Physiol Lung Cell Mol Phys-
iol 2004, 287(6):L1073-1080.
2. Solligard E, Juel IS, Bakkelund K, Johnsen H, Saether OD, Gronbech
JE, Aadahl P: Gut barrier dysfunction as detected by intestinal
luminal microdialysis.  Intensive Care Med 2004, 30(6):1188-1194.
3. Solligard E, Juel IS, Bakkelund K, Jynge P, Tvedt KE, Johnsen H, Aadahl
P, Gronbech JE: Gut luminal microdialysis of glycerol as a
marker of intestinal ischemic injury and recovery.  Crit Care
Med 2005, 33(10):2278-2285.
4. Tenhunen JJ, Kosunen H, Alhava E, Tuomisto L, Takala JA: Intestinal
luminal microdialysis: a new approach to assess gut mucosal
ischemia.  Anesthesiology 1999, 91(6):1807-1815.
5. Solligard E, Wahba A, Skogvoll E, Stenseth R, Gronbech JE, Aadahl P:
Rectal lactate levels in endoluminal microdialysate during
routine coronary surgery.  Anaesthesia 2007, 62(3):250-258.
6. Eisenberg EJ, Conzentino P, Eickhoff WM, Cundy KC: Pharmacoki-
netic measurement of drugs in lung epithelial lining fluid by
microdialysis: aminoglycoside antibiotics in rat bronchi.  J
Pharmacol Toxicol Methods 1993, 29(2):93-98.
7. Dargaville PA, South M, Vervaart P, McDougall PN: Validity of
markers of dilution in small volume lung lavage.  Am J Respir
Crit Care Med 1999, 160(3):778-784.
8. Kaulbach HC, White MV, Igarashi Y, Hahn BK, Kaliner MA: Estima-
tion of nasal epithelial lining fluid using urea as a marker.  J
Allergy Clin Immunol 1993, 92(3):457-465.
9. Rennard SI, Basset G, Lecossier D, O'Donnell KM, Pinkston P, Martin
PG, Crystal RG: Estimation of volume of epithelial lining fluid
recovered by lavage using urea as marker of dilution.  J Appl
Physiol 1986, 60(2):532-538.
10. Jones KP, Edwards JH, Reynolds SP, Peters TJ, Davies BH: A com-
parison of albumin and urea as reference markers in bron-
choalveolar lavage fluid from patients with interstitial lung
disease.  Eur Respir J 1990, 3(2):152-156.
11. Eisenberg EJ, Eickhoff WM: A method for estimation of extracel-
lular concentration of compounds by microdialysis using
urea as an endogenous recovery marker in vitro validation.
J Pharmacol Toxicol Methods 1993, 30(1):27-31.
12. Matsukawa Y, Lee VH, Crandall ED, Kim KJ: Size-dependent dex-
tran transport across rat alveolar epithelial cell monolayers.
J Pharm Sci 1997, 86(3):305-309.
13. Salzman AL, Wang H, Wollert PS, Vandermeer TJ, Compton CC,
Denenberg AG, Fink MP: Endotoxin-induced ileal mucosal
hyperpermeability in pigs: role of tissue acidosis.  Am J Physiol
Gastrointest Liver Physiol 1994, 266(4 pt 1):G633-646.
14. Han X, Fink MP, Uchiyama T, Yang R, Delude RL: Increased iNOS
activity is essential for pulmonary epithelial tight junction
dysfunction in endotoxemic mice.  Am J Physiol Lung Cell Mol Phys-
iol 2004, 286(2):L259-267.
15. Kawedia JD, Nieman ML, Boivin GP, Melvin JE, Kikuchi KI, Hand AR,
Lorenz JN, Menon AG: Interaction between transcellular and
paracellular water transport pathways through Aquaporin 5
and the tight junction complex.  PNAS 2007, 104(9):3621-3626.
16. Dreyfuss D, Saumon G: Ventilator-induced lung injury: lessons
from experimental studies.  Am J Respir Crit Care Med 1998,
157(1):294-323.
17. Parsons PE, Matthay MA, Ware LB, Eisner MD: Elevated plasma
levels of soluble TNF receptors are associated with morbid-
ity and mortality in patients with acute lung injury.  Am J Phys-
iol Lung Cell Mol Physiol 2005, 288(3):L426-31.
18. Hannon JP, Bossone CA, Wade CE: Normal physiological values
for conscious pigs used in biomedical research.  Lab Anim Sci
1990, 40(3):293-298.
19. Herkner H, Muller MR, Kreischitz N, Mayer BX, Frossard M, Joukha-
dar C, Klein N, Lackner E, Muller M: Closed-chest microdialysis
to measure antibiotic penetration into human lung tissue.
Am J Respir Crit Care Med 2002, 165(2):273-276.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Respiratory Research 2007, 8:78 http://respiratory-research.com/content/8/1/78
Page 11 of 11
(page number not for citation purposes)
20. Tomaselli F, Maier A, Matzi V, Smolle-Juttner FM, Dittrich P: Pene-
tration of meropenem into pneumonic human lung tissue as
measured by in vivo microdialysis.  Antimicrob Agents Chemother
2004, 48(6):2228-2232.
21. Zeitlinger M, Muller M, Joukhadar C: Lung microdialysis--a pow-
erful tool for the determination of exogenous and endog-
enous compounds in the lower respiratory tract (mini-
review).  Aaps J 2005, 7(3):E600-8.
22. Grubb BR, Jones JH, Boucher RC: Mucociliary transport deter-
mined by in vivo microdialysis in the airways of normal and
CF mice.  Am J Physiol Lung Cell Mol Physiol 2004, 286(3):L588-95.
23. Bayat S, Louchahi K, Verdiere B, Anglade D, Rahoui A, Sorin PM, Tod
M, Petitjean O, Fraisse F, Grimbert FA: Comparison of 99mTc-
DTPA and urea for measuring cefepime concentrations in
epithelial lining fluid.  Eur Respir J 2004, 24(1):150-156.
24. Gladden LB: Lactate metabolism: a new paradigm for the
third millennium.  J Physiol 2004, 558(Pt 1):5-30.
25. Routsi C, Bardouniotou H, Delivoria-Ioannidou V, Kazi D, Roussos C,
Zakynthinos S: Pulmonary lactate release in patients with
acute lung injury is not attributable to lung tissue hypoxia.
Critical Care Medicine 1999, 27(11):2469-2473.
26. Kobayashi S, Kondo S, Juni K: Permeability of peptides and pro-
teins in human cultured alveolar A549 cell monolayer.  Pharm
Res 1995, 12(8):1115-1119.
27. Foxdal P, Sjödin B, Rudstam H, Östman C, Östman B, Hedenstierna
GC:  Lactate concentration differences in plasma, whole
blood, capillary finger blood and erythrocytes during sub-
maximal graded exercise in humans.  European Journal of Applied
Physiology 1990, 61(3):218-222.
28. Hamrin K, Rosdahl H, Ungerstedt U, Henriksson J: Microdialysis in
human skeletal muscle: effects of adding a colloid to the per-
fusate.  J Appl Physiol 2002, 92(1):385-393.